1905
華紙
+0.05 (+0.38%)13.101,486成交張數–本益比0.84股價淨值比0.00%殖利率2026-09-16資料日期
綜合損益表公開資訊觀測站申報原值 · 年度(第 4 季累計) · 每一格 = 該期對去年同期的成長率
營業收入202518,767年增 -9.6%
毛利率20252.7%最新一期
營業利益率2025-8.1%最新一期
每股盈餘2025-0.56
| 會計項目 | 走勢 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業收入合計 | – | +3.2% | +5.8% | -13.9% | -10.0% | +18.3% | +7.3% | -11.4% | -0.9% | -9.6% | |
| 營業成本合計 | – | +1.4% | +6.3% | -10.2% | -10.8% | +13.0% | +7.5% | -5.8% | -3.2% | -5.0% | |
| 生物資產當期公允價值減出售成本之變動利益(損失) | – | – | – | – | – | +919.5% | -170.8% | – | – | -398.9% | |
| 營業毛利（毛損） | – | +22.4% | +1.2% | -48.2% | +2.4% | +93.5% | +6.2% | -57.3% | +41.8% | -67.4% | |
| 營業毛利（毛損）淨額 | – | +22.4% | +1.2% | -48.2% | +2.4% | +93.5% | +6.2% | -57.3% | +41.8% | -67.4% | |
| 營業費用合計 | – | +1.9% | +15.3% | -8.9% | +2.2% | +30.5% | +8.5% | -15.7% | +7.5% | -3.0% | |
| 營業利益（損失） | – | +105.7% | -25.8% | -165.3% | – | – | -11.7% | -457.1% | – | – | |
| 稅前淨利（淨損） | – | +165.6% | -24.8% | -154.5% | – | – | +3.8% | -228.3% | – | – | |
| 所得稅費用（利益）合計 | – | – | -14.3% | -144.4% | – | +588.2% | -91.5% | – | – | – | |
| 繼續營業單位本期淨利（淨損） | – | +107.7% | -27.1% | -157.1% | – | – | +16.5% | -202.7% | – | – | |
| 本期淨利（淨損） | – | +107.7% | -27.1% | -157.1% | – | – | +16.5% | -202.7% | – | – | |
| 本期綜合損益總額 | – | – | +13.8% | -155.4% | – | – | +37.5% | -135.5% | – | -85.4% | |
| 母公司業主（淨利∕損） | – | +58.2% | -28.0% | -155.0% | – | – | -8.7% | -228.6% | – | – | |
| 基本每股盈餘 | – | +60.0% | -28.6% | -155.0% | – | – | -8.9% | -229.3% | – | – |
金額為公司申報原值除以一千(百萬元,四捨五入),每股金額為元。年度為第 4 季的年初至今累計數。走勢條是歷史各期的相對大小,藍為正、綠為負。年增以去年同期為基期,基期非正數或變動超過十倍時不列。 權益變動表在申報資料分頁。